Current Contribution of Four Biotechnologies to New Zealand's Primary Sector
Over the last several decades, changes to production technologies have significantly increased output from the primary sector. The contribution of improved genetics has been variously estimated, and the impacts of genetic engineering have received much attention. The present research estimated the economic impact of four modern biotechnologies (other than genetic engineering) on the primary sector. Information from interviews with key informants was incorporated into a cost-benefit analysis to estimate these impacts. The net contribution was estimated at $266 million per year, with impacts spread unevenly through the sector and across biotechnologies.
|Date of creation:||2006|
|Date of revision:|
|Contact details of provider:|| Web page: http://www.iaae-agecon.org/|
More information through EDIRC
When requesting a correction, please mention this item's handle: RePEc:ags:iaae06:25411. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (AgEcon Search)
If references are entirely missing, you can add them using this form.